Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Delirium × CNS × Clear all

Phase

Phase 4 2 Phase NA 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Genitourinary 1 CNS 1

Conditions

Brain Neoplasms 475 Glioma 225 Glioblastoma 218 Neoplasms 60 Neuroblastoma 55 Central Nervous System Neoplasms 55 Breast Neoplasms 53 Meningioma 47 Astrocytoma 43 Neuroma, Acoustic 38 Spinal Cord Neoplasms 35 Neurofibromatosis 1 32 Sarcoma 29 Oligodendroglioma 29 Lung Neoplasms 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 27 Lymphoma 27 Neoplasm Metastasis 26 Head and Neck Neoplasms 23 Melanoma 22 Lymphoma, Non-Hodgkin 22 Leukemia 22 Meningeal Carcinomatosis 21 Medulloblastoma 21 Hodgkin Disease 21 Burkitt Lymphoma 20 Testicular Neoplasms 19 Lymphoma, Follicular 19 Multiple Myeloma 18 Gliosarcoma 18

Interventions

Saline Solution 1 Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07398066 2026-02-09

DEX-NEURO

University of Malaya

Phase NA Not yet recruiting

Brain Neoplasms, Delirium, Meningioma, Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡